TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa. It offers TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to TruScreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
Frequently asked questions
What sector does TruScreen Group Limited (TRU) operate in?
TruScreen Group Limited belongs to the Healthcare sector and operates in the Medical Devices industry.
What is TruScreen Group Limited (TRU) current stock price?
As of the latest data, TruScreen Group Limited stock price is NZ$0.02, with a previous close of NZ$0.02.
What is TruScreen Group Limited (TRU) current market capitalization?
TruScreen Group Limited market cap is approximately 15.10 million.
Does TruScreen Group Limited (TRU) pay dividends?
No. TruScreen Group Limited does not pay a dividend.
What is TruScreen Group Limited (TRU) beta (volatility) score?
TruScreen Group Limited has a beta of -0.061, indicating lower volatility than the overall market.
